Luke Sergott

Stock Analyst at Barclays

(0)
# 3400
Out of 5,240 analysts
260
Total ratings
35.29%
Success rate
0.56%
Average return
22 Stocks
Name Action Price Target Current % Upside Ratings Updated
A
Agilent Technologies
Maintains: Underweight
145 135
145.52 -7.23% 6 Nov 27, 2024
Revvity
Maintains: Overweight
140 135
121.6 11.02% 7 Nov 25, 2024
Twist Bioscience
Maintains: Overweight
55 52
46.12 12.75% 16 Nov 19, 2024
Fortrea Holdings
Maintains: Equal-Weight
20 25
17.85 40.06% 7 Nov 11, 2024
Certara
Maintains: Equal-Weight
14 12
11.83 1.44% 14 Nov 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
135 145
138.78 4.48% 14 Nov 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underweight
330 360
407.98 -11.76% 16 Nov 4, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
260 255
198.94 28.18% 19 Nov 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
21 19
16.09 18.09% 8 Nov 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
28 25
21.75 14.94% 20 Oct 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
330 275
202.48 35.82% 16 Oct 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
620 610
560.54 8.82% 23 Oct 23, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
285 275
240.31 14.44% 31 Oct 23, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
230 210
176.03 19.3% 2 Aug 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
14 17
12.63 34.6% 16 Aug 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
47 63
n/a n/a 16 Jun 28, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
3 2
1.94 3.09% 4 May 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
140 125
n/a n/a 7 May 12, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Equal-Weight
43
n/a n/a 13 May 11, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
29 25
n/a n/a 3 Dec 27, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
42
n/a n/a 1 Mar 3, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: In-Line
22 21
n/a n/a 1 Apr 24, 2020